Mark Alan Rosen, M.D., Ph.D., William Lee, M.D., Ph.D.

Location: Abramson Cancer Center of the University of Pennsylvania - Pennsylvania

Proposal: Use of PET and MR Imaging Biomarkers to Predict Response of Renal Cell Carcinoma to Tyrosine Kinase Inhibitor Therapy